Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Commends Senate for Approval of User Fee Package

Jun 27 2012
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate.

2012 BIO International Convention Closes in Boston with Unprecedented Partnering Activity within BIO Business Forum

Jun 21 2012
The global event for biotechnology brings together industry leaders for networking, partnering, and deal-making.

BIO Applauds Senate Vote to Support Science-based Policymaking for Agricultural Biotechnology

Jun 21 2012
The 73 to 26 vote against the amendment highlights the value the U.S. Congress places on science-based policymaking and the importance of agricultural innovation.

BIO Hails House Passage of Reconciled User Fee Package

Jun 21 2012
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on unanimous passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. House of Representatives.

BIO Study Quantifies Economic Contribution of University & Non-Profit Inventions

Jun 21 2012
The Biotechnology Industry Organization (BIO) released a report on the significant economic impact of university and non-profit institution patent licensing on the U.S. economy.

2012 BIO International Convention Highlights: Days Two and Three

Jun 20 2012
The world’s largest biotechnology event, 2012 BIO International Convention, showcased the global financial and business developments that are shaping the biotechnology sector during the Convention’s second day. 

Intellectual Property Encourages Collaboration, R&D in Developing Economies

Jun 20 2012
The Biotechnology Industry Organization(BIO) unveiled a report on the role of intellectual property rights in encouraging upstream research and development as well as downstream commercialization of biotechnology at the 2012 BIO International Convention.

Scientific American releases its 4th Annual Worldview Report and Scorecard at the BIO International Convention in Boston

Jun 20 2012
The 4th Annual Scientific American Worldview Report and Scorecard – the most comprehensive country-by-country analysis of biotechnology – reveals the parameters essential for building a successful biotechnology hub in today’s increasingly global industry.

Americans Remain Optimistic About Future of Biotechnology Despite Serious Industry Concerns

Jun 20 2012
The Biotechnology Industry Organization (BIO) today unveiled several new opinion surveys at the 2012 BIO International Convention, taking place this week in Boston.

New Coalition Brings Life Science Education to the National Stage

Jun 20 2012
Forty-one state bioscience organizations announce today the formation of the Coalition of State Bioscience Institutes to ensure America’s leadership in bioscience innovation.